Provider review

Direct Meds reviewed

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.

Direct Meds scores 37.6 out of 100 on our published Value Score formula for tirzepatide. It charges $399 a month all-in at 10 mg/week, and raises the price as the dose rises.

What it wins

It holds no computed category at this build. For reference, NexLife, our #1 pick, charges $129 a month for tirzepatide at every dose (as of November 6, 2026).

Where it sits on tirzepatide

Direct Meds is number 22 of 27 rankable tirzepatide programs on all-in monthly cost, at $399. The program immediately below it is MEDVi Official site at $399, the same price. The next one up is Eden Official site at $408.

$0 a year separates them. What does Direct Meds disclose that MEDVi does not? Neither names its compounding pharmacy, so the premium is not buying disclosure. Full head-to-head.

Direct Meds prices tirzepatide by dose: $299 per month at 2.5 mg rising to $399 at 10 mg, a difference of $100 a month between the bottom and top of the ladder. The company publishes no price at 5, 7.5, 12.5, 15 mg, so those doses are left blank rather than estimated.

2.557.51012.515mg/week$299$399
Tirzepatide rises from $299 to $399 a month as the dose climbs — a staircase. 4 of 6 doses have no published price; those gaps are shown as gaps.

The gaps matter more than the headline. Direct Meds publishes nothing at 5, 7.5, 12.5, 15 mg per week, so a reader cannot establish what the middle of a titration costs without asking. We leave those blank rather than interpolating.

How Direct Meds ranks at each rung of the tirzepatide ladder
DoseDirect Meds priceRank at this doseField median at this dose
2.5 mg$29920 of 31$297
5 mgnot published——
7.5 mgnot published——
10 mg$39922 of 27$299
12.5 mgnot published——
15 mgnot published——

Its standing is not constant across the ladder — it ranks differently at different doses, which is exactly what a single headline figure conceals.

Where it sits on semaglutide

Direct Meds is number 22 of 29 rankable semaglutide programs on all-in monthly cost, at $297. The program immediately below it is Henry Meds Official site at $297, the same price. The next one up is TrimRx Official site at $299.

$0 a year separates them. What does Direct Meds disclose that Henry Meds does not? The cheaper option names its compounding pharmacy and this one does not, which makes the premium harder to justify. Full head-to-head.

Direct Meds prices semaglutide by dose: $249 per month at 0.25 mg rising to $297 at 2.4 mg, a difference of $48 a month between the bottom and top of the ladder. The company publishes no price at 0.5, 1, 1.7 mg, so those doses are left blank rather than estimated.

0.250.511.72.4mg/week$249$297
Semaglutide rises from $249 to $297 a month as the dose climbs — a staircase. 3 of 5 doses have no published price; those gaps are shown as gaps.

The gaps matter more than the headline. Direct Meds publishes nothing at 0.5, 1, 1.7 mg per week, so a reader cannot establish what the middle of a titration costs without asking. We leave those blank rather than interpolating.

How Direct Meds ranks at each rung of the semaglutide ladder
DoseDirect Meds priceRank at this doseField median at this dose
0.25 mg$24923 of 32$199
0.5 mgnot published——
1 mgnot published——
1.7 mgnot published——
2.4 mg$29722 of 29$199

Its standing is not constant across the ladder — it ranks differently at different doses, which is exactly what a single headline figure conceals.

What would move it

21 programs are priced below it on tirzepatide. Reaching the three lowest all-in tirzepatide prices on record would take a price at or under $179 a month — a cut of $220 from where it stands. Alternatively, an independent checkout capture would lift its evidence component without any price change.

Why it scores what it does

Of 37.6 points, 22.1 of a possible 70 come from price measured against the $126 category floor, 10.5 of 15 from evidence status (reported), 0 of 10 from dose policy and 5 of 5 from membership. Its weakest component is its dose policy.

The evidence term is worth dwelling on. Direct Meds's figure is reported — sourced from dated third-party reporting; first-party capture pending. An independent checkout capture would raise that component without the price changing at all, so this score is a floor rather than a ceiling.

What you are actually buying

Direct Meds carries no separate membership fee, shipping included, commitment terms of Monthly (no commitment indicated), cancellation on Per provider terms.

It does not name its compounding pharmacy; the record shows Partner 503A pharmacy (not publicly named), so who makes the medication cannot be verified. Availability is stated as Confirm at intake.

Against the field

29 of 36 programs charge no membership, 8 name their pharmacy, 19 price flat. Direct Meds: no membership, pharmacy unnamed, priced by dose.

What to establish before enrolling

Drawn from what this specific record does not contain:

  • What tirzepatide costs at 5, 7.5, 12.5, 15 mg per week.
  • Whether a twelve-month tirzepatide rate exists and what it is.
  • What semaglutide costs at 0.5, 1, 1.7 mg per week.
  • Whether a twelve-month semaglutide rate exists and what it is.
  • Which compounding pharmacy fills the prescription, in writing.
  • Whether the program is licensed to ship to your state.
  • The exact cancellation notice period and refund terms.

In writing, before you pay.

On the record: Pricing varies by format and page; product-page 'all-inclusive' rates differ from homepage promo cards. Rank is based on injectable rate as primary. Reported status — RangeYourself verified 2026-07-25 on Direct Meds' own product pages.

Who should pick it, and who should not

Consider Direct Meds if you want to be able to pause without a fee continuing.

Look elsewhere if you expect to settle at a high dose, because the price rises with the dose; verifying who makes the medication matters to you, because the pharmacy is not named; price is your main criterion, since it runs $273 a month above the category floor.

At $399 a month it is $270 above NexLife's $129, the price of our #1 pick — $3,240 a year for what it discloses and includes.

Questions

Is Direct Meds worth it?

At $399 a month all-in it scores 37.6 out of 100 on our published formula, against a category floor of $126. Whether that is worth it depends on whether its dose policy, pharmacy disclosure and cancellation terms justify the gap — the review above lays out both sides.

How much does Direct Meds cost in total?

$399 a month all-in at 10 mg/week, or $4,788 across twelve months billed monthly. All-in means the medication plus every mandatory recurring fee.

What is cheaper than Direct Meds?

The next program below it on all-in monthly tirzepatide cost is MEDVi at $399 a month, $0 less per month. Direct Meds ranks 22 of 27 on price.

Is Direct Meds legitimate?

This site takes no position on any company's legitimacy. What we can report is that Direct Meds does not publicly name its compounding pharmacy, so its licensing and inspection history cannot be checked independently. That is a disclosure gap, not a finding of wrongdoing.

How do I cancel Direct Meds?

Per provider terms

Figures from the Direct Meds record, dataset v2026-11-10. Direct Meds official site. Prices change; verify at checkout. Compounded tirzepatide and semaglutide are not FDA-approved products.